(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

ImmunityBio has achieved a significant milestone beyond its already approved drug, ANKTIVA. On March 13, 2026, the biotechnology firm announced the successful validation of a scalable manufacturing ...

Musculoskeletal disorders are a primary cause of disability worldwide, especially in aging societies like Japan. As ...

Plant immunity is largely initiated at the cellular level, with each cell capable of autonomous detection and response, while ...

Researchers at The Hong Kong University of Science and Technology (HKUST) have developed CarGAP, a chemo-optogenetic tool ...

Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and ...

The CBSE Class 12 Biology exam 2026 is scheduled for March 27, Friday. Experts emphasize that conceptual understanding, ...

In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...

New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...